Trevena
TRVN
#11301
Rank
A$0.01 M
Marketcap
A$0.01717
Share price
0.00%
Change (1 day)
12.68%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -A$46.06 Million

According to Trevena's latest financial reports the company's current earnings are A$0.54 Million. In 2023 the company made an earning of -A$51.99 Million, an increase over its 2022 earnings that were of -A$75.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$46.06 Million-11.4%
2023 -A$51.99 Million-30.69%
2022 -A$75.01 Million1.38%
2021 -A$74 Million78.04%
2020 -A$41.56 Million21.3%
2019 -A$34.27 Million-13.91%
2018 -A$39.8 Million-59.75%
2017 -A$98.88 Million-31.77%
2016 -A$0.15 Billion101.73%
2015 -A$71.84 Million1.14%
2014 -A$71.03 Million114.83%
2013 -A$33.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$14.72 B-33,224.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.00 B-24,861.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.28 Billion 2,778.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$14.73 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-A$89.87 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.9 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA